Article
ACLY and CKD: A Mendelian Randomization Analysis
21 Apr 2022
Abstract excerpt
Introduction Adenosine triphosphate-citrate lyase (ACLY) inhibition is a therapeutic strategy under investigation for atherosclerotic cardiovascular disease, nonalcoholic steatohepatitis, and metabolic syndrome. Mouse models suggest that ACLY inhibition could reduce inflammation and kidney fibrosis. Genetic analysis of ACLY in chronic kidney disease (CKD) has not been performed. Methods We constructed a genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
